Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple

Withdrawn

• Conditions: Sexuality
• Interventions: Other: To evaluate the prevalence of sexual disorders in patients receiving AMP

• Registration Number: NCT03132818
• Lead Sponsor: Centre Hospitalier Universitaire, Amiens

Brief Summary

Sexual disorders associated with medical aid for procreation have already been demonstrated in several studies. However, few of them are interested in the problem of patients in charge of donating gametes, and if studied, it is often restricted to donating sperm to a small number of patients. For this reason, it would be interesting to study the impact of the intake and in charge and the treatments of the Medical Aid to the Procreation on this population of patients (including the patients treated in donation of sperm but also Those supported in oocyte donation)

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-04-14
• Study First Submitted QC: 2017-04-27
• Study First Posted: 2017-04-28
• Study Start: 2017-07-20
• Primary Completion: 2019-02-20
• Study Completion: 2019-02-20
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-15
• Last Update Posted: 2020-07-17

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Couple, male and female, meeting the legal criteria for access to medically assisted procreation: a couple, a woman under the age of 43, who can testify to a life together. Then breakdown into 3 inclusion groups:

  • Group 1: Patients undergoing AMP with oocyte donation
  • Group 2: couples supported in AMP with sperm donation
  • Group 3: torque supported in intra torque AMP.

Exclusion Criteria

• Patients who do not meet the legal criteria for access to the MPA.
• Patients in charge of Medical Assistance for Procreation "Viral Risk"
• Patients undergoing medical aid for procreation for pre-existing sexual dysfunction.
• Patients awaiting embryo reception.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients undergoing AMP with oocyte donation	To evaluate the prevalence of sexual disorders in patients receiving AMP	-
Couples supported in AMP with sperm donation	To evaluate the prevalence of sexual disorders in patients receiving AMP	-
Couples supported in AMP intra torque	To evaluate the prevalence of sexual disorders in patients receiving AMP	-

Primary Outcome Measures

Name	Time	Method
Analysis of anonymous sexual well-being questionnaires: one reserved for men, another reserved for women	1 year	Analysis of anonymous sexual well-being questionnaires: one reserved for men, another reserved for women

Trial Locations

Locations (1)

CHU Amiens Picardie; 🇫🇷 Amiens, Picardie, France